And now it’s time to share Beauty and the Beast’s final version. To comprehend the Turkish Pharmaceutical Market potential completely, it might be valuable to review “opportunities and threads” together after ranking strengths and weaknesses of the industry individually. Turkey, with its refugee inflated >82MM population (TUIK/2018), has a statistically good potential vs. its peers among OECD countries with its current…
Month: March 2019
7 Drugs Expected to Be Blockbusters by 2023
Biospace shared the summary of Clarivate Analytics’ report “Cortellis Drugs to Watch,” in which seven new drugs identified as blockbusters by 2023, here is the list; #1. AbbVie’s Upadacitinib. On December 20, 2018, AbbVie submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA)and a marketing authorization application (MAA) to the European Medicines Agency (EMA)for…